Clinical trial
A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil…
NCT00382213 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00382213 |
|---|---|
| Title | A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis |
| Official title | A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Placebo |
| Enrollment | 210 |
| Start date | Jun 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Sep 28, 2006 |
| Last update posted | Jun 1, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: